Area of Research: BRCA Mutations

2023 Grant Recipients

• Simon Gayther, PhD, Cedars-Sinai Medical Center
  Collaborative Research Development Grant
  iPSC Modeling of Ovarian Cancers in BRCA1 and 2 Mutation Carriers

2022 Grant Recipients

• Jasmine Plummer, PhD, Cedars-Sinai Medical Center
  Early Career Investigator Grant
  Chemopreventative Targets in BRCA1 Carrier Models with P53 Lesions (Gail Baird Foundation Research Grant Recipient)
• Sammy Ferri-Borgogno, PhD, MD Anderson Cancer Center
  Early Career Investigator Grant
  BRCA-deficient Ovarian Cancer and IFITM3: a New Power Couple

2021 Grant Recipients

• Anup Singh, PhD, La Jolla Institute for Immunology
  Mentored Investigator Grant
  Studying the Role of BRCA1 in Regulating Heterochromatin Structure and Function in Ovarian Cancer

2020 Grant Recipients

• Morozov Yaroslav, PhD, University of Pennsylvania
  Mentored Investigator Grant
  The BRCA1-A as a Determinant of Chemotherapy Response in ATM Mutated Cells

2019 Grant Recipients

• John Krais, PhD, Fox Chase Cancer Center
  Mentored Investigator Grant
  Examining the Role of RNF168 in BRCA1 Mutant Ovarian Cancer
• Zihua Gong, MD, PhD, Cleveland Clinic
  Early Career Investigator Grant
  DNA Repair Pathways as Targets for Therapy-Resistant Ovarian Cancer

2018 Grant Recipients

• Shih-Hsun Chen, PhD, Beckman Research Institute of the City of Hope
  Mentored Investigator Grant
  Targeting de-poly (ADP-ribosyl)ation for Ovarian Cancer Therapy
• Katherine Fuh, MD, PhD, Washington University in St. Louis
  Early Career Investigator Grant
  Inhibition of Metastasis in BRCA2-associated Ovarian Cancers
• Jian Yuan, PhD, Mayo Clinic
  Early Career Investigator Grant
  The Role of BRD9-Rad51 Axis in Chemoresistance in Ovarian Cancer

2017 Grant Recipients

• Priyanka Verma, PhD, University of Pennsylvania
  Mentored Investigator Grant
  BRCA-Independent DNA Repair Pathways in Ovarian Cancer

2016 Grant Recipients

• Nur Yucer, PhD, Cedars-Sinai Medical Center
  Mentored Investigator Grant
  Modeling Mullarian HGSC Using BRCA1 Patient Derived iPSCs
• Alberto Ciccia, PhD, Columbia University Medical Center
  Early Career Investigator Grant
  Defining the Molecular Mechanisms of BRCA1-dependent Tumor Suppression
• Zihua Gong, MD, PhD, MD Anderson Cancer Center
  Early Career Investigator Grant
  DNA Repair Pathways as Target for Therapy-Resistant Ovarian Cancer

2015 Grant Recipients

• Petar Jelinic, PhD, Memorial Sloan Kettering Cancer Center
  Mentored Investigator Grant
  EMSY Suppresses HDR in a BRCA2-interaction-independent Manner
• Sarah Adams, MD, University of New Mexico
  Early Career Investigator Grant
  A Combination Therapy for Hereditary Ovarian Cancer

2014 Grant Recipients

• Ryan B. Jensen, PhD, Yale University
  Early Career Investigator Grant
  A Cellular Switch to Modulate BRCA2-mediated Tumor Progression
• Ronen Marmorstein, PhD, University of Pennsylvania
  Collaborative Research Development Grant
  Chromatin Regulatory Mechanisms in Ovarian Cancer

2012 Grant Recipients

• Melinda Yates, PhD, MD Anderson Cancer Center
  Mentored Investigator Grant
  Unraveling the Initiation of Ovarian Cancer: The BRCA1-Heterozygous Mouse as a Model System

2011 Grant Recipients

• Sarah Adams, MD, University of Pennsylvania
  Early Career Investigator Grant
  Development of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer

2007 Grant Recipients

• Qin Yang, MD, PhD, University of Washington
  Individual Investigator Award
  BRCA/AKT1 Pathway in Ovarian Cancer

2005 Grant Recipients

• Xiaochun Yu, MD, PhD, University of Michigan
  Individual Investigator Award
  How Hereditary and Non-Hereditary Cancer May Have Something in Common

2004 Grant Recipients

• Wael El Shamy, PhD, Dana Farber Cancer Institute
  Individual Investigator Award
  Another Protein Made by BRCA1 and its Role in Ovarian Cancer